That puts the annual cost range at: The oral semaglutide option at $149 per month ($1,788/year) makes Henry one of the cheapest GLP-1 telehealth platforms available
AI-driven automation continues to show promising results, with CoverMyMeds reporting an 83% reduction in turnaround time and a 26% increase in approval rates in pilot programs
For non-diabetic patients whose insurance denies coverage entirely, the cash-pay options are the same as for everyone else: NovoCare ($149 to $349/month), LillyDirect ($299 to $449/month), or patient assistance programs if income-eligible
The cash-pay prices for these medications are undoubtedly expensive, and the patent system certainly preferences big money pharma corporations but if Im calling balls and strikes, this one feels like they got caught out
Adjusting frequency or timing may help some patients, though dose reduction typically diminishes weight loss benefits
Its triple-action approachtargeting appetite, digestion, and energy expenditure at the same timehelps explain why the weight loss numbers are so striking